Introduction
NF-kB regulates normal and pathological processes including neoplasia in a tissue context-dependent manner (Ghosh et al., 1998; Karin and Ben-Neriah, 2000; Pomerantz and Baltimore, 2000; Baldwin, 2001 ). The NF-kB/Rel transcription factor family in mammals is comprised of five subunits RelA/p65, p105/p50, p100/ p52, c-Rel and RelB, which share a 300 amino-acid Nterminal Rel homology domain responsible for DNAbinding, dimerization and protein-protein interactions. NF-kB is activated in response to a range of stimuli including irradiation, mechanical stress as well as microbial infection. NF-kB subunits function as homoor heterodimers and are held in the cytoplasm by the inhibitory IkB complex that masks a nuclear localization sequence (NLS) until activated through the IkB kinase (IKK) complex. The IKK complex phosphorylates IkB on specific serine residues, which leads to recruitment of the SCF b-TrCP ubiquitin ligase complex, followed by polyubiquitination and degradation of the IkB complex by the 26S proteosome (Karin and BenNeriah, 2000) . Upon IkB degradation, NF-kB translocates to the nucleus, binds its cognate DNA-binding sites and regulates transcription of its target genes. Conserved NF-kB roles include morphogenesis, apoptosis and inflammation (Govind, 1999) ; however, the specific biological effects of NF-kB vary in different cell types and tissue contexts. For example, NF-kB can either promote or oppose apoptosis depending on the setting (Baldwin, 2001) .
The skin represents the primary barrier against insult and injury from the outside environment. Its two major layers, the epidermis and the dermis, serve different functions. The dermis, generated and maintained by mesodermal fibroblasts, is comprised of a collagenous protein matrix that provides mechanical and biological support. Overlying the dermis is the self-renewing stratified epithelium, the epidermis, which is comprised primarily of ectoderm-derived keratinocytes. Proliferating keratinocytes in the epidermal basal layer adhere to the dermis via the cutaneous basement membrane zone. These cells undergo cell cycle arrest, migrate outward to form the suprabasal layer of the epidermis and enter a terminal differentiation pathway, resulting in programmed cell death and the formation of the cutaneous barrier. Gene regulatory programs controlling cutaneous homeostasis are incompletely understood. Prior work points to a role for the NF-kB axis in the regulation of epidermal proliferation, apoptosis and response to injury as well as in an increased incidence in the development of squamous cell carcinoma (Seitz et al., 1998 (Seitz et al., , 2000a Qin et al., 1999; van Hogerlinden et al., 1999; Kaufman and Fuchs, 2000; Abeyama et al., 2000) . Epidermis expressing the IkBaM super-repressor lacks NF-kB activity and is hyperplastic, as opposed to the hypoplastic epidermis of mice with epidermis expressing NF-kB subunits p50 and p65 (Seitz et al., 1998) . Epidermal NF-kB inhibition of proliferation is due, in part, to the induction of cyclin-dependent kinase inhibitor p21redundancy among family members. In contrast to its effects in epidermal keratinocytes, NF-kB does not appear to inhibit growth of fibroblast cell lines. In mouse embryo fibroblasts and mouse fibroblast cell line NIH3T3s, the inhibition of NF-kB has been shown to halt proliferation through the lack of cyclin D1 induction, which would promote the G1/S transition (Guttridge et al., 1999; Hinz et al., 1999) . TNF-a, a known NF-kB inducer as well as target, has an antiproliferative effect in keratinocytes, but supports the proliferation of fibroblasts both in vitro and in vivo (Sugarman et al., 1985; Vieira et al., 1996; Kouba et al., 2001) , further highlighting the potentially differing roles for NF-kB in epidermal and dermal cells. The mechanisms by which a family of transcription factors might elicit different cellular responses in different tissues are not well understood.
To gain insight into NF-kB gene regulatory targets in adjacent epidermal and dermal compartments, we induced NF-kB activity in primary human epidermal keratinocytes and dermal fibroblasts and examined effects on the expression of 12 435 genes. NF-kB induces proinflammatory and antiapoptotic genes in both keratinocytes and fibroblasts, but exerts differential effects on genes regulating proliferation. NF-kB induces p21 CIP1 in epidermal cells but not dermal fibroblasts, and p21 CIP1 is sufficient to inhibit the proliferation of both cell types. NF-kB induces growth inhibitory factor/ metallothionein 3 (GIF) in both cell types, but GIF inhibits proliferation only in epidermal cells. These data support two paradigms for differential biological effects induced by the same transcription factor in adjacent tissue compartments: (1) differential induction of target genes that exert similar effects in different cell types and (2) induction of the same target genes that exert differential effects depending on cell type.
Results
Immunoblotting of primary skin cell extracts was performed to examine expression of NF-kB subunits in human skin. All five NF-kB subunits are expressed in both epidermal keratinocytes and dermal fibroblasts (Figure 1a) . To determine if NF-kB is transcriptionally active in both epidermis and dermis, skin tissue was examined from two lines of mice transgenic for NF-kBdependent LacZ expression (Schmidt-Ullrich et al., 1996) . We found similar expression patterns in both lines of mice. In epidermis, NF-kB-directed gene expression displays a biphasic basal and suprabasal pattern ( Figure 1b ). NF-kB activity is also found in dermal cells with localization and morphology that correspond to that of dermal fibroblasts ( Figure 1c ). These data indicate that NF-kB directs gene expression in both epidermal and dermal cells and that the location of its activity in epidermis is in agreement with prior functional data implicating it in the control of epidermal proliferation and cell death (Guttridge et al., 1999; Seitz et al., 1998 Seitz et al., , 2000a .
Previous work demonstrated that NF-kB p50 and p65 subunits inhibit keratinocyte proliferation and that the NF-kB super-repressor IkBaM causes hyperproliferation (Seitz et al., 1998 (Seitz et al., , 2000a van Hogerlinden et al., 1999) . To test the proliferative effects of the other three NF-kB subunits, we expressed p52, c-Rel and RelB via high titer retroviruses. These three subunits also inhibited keratinocyte proliferation while p50DSP, a transcriptionally inactive p50 mutant (Logeat et al., 1991) , did not ( Figure 2a and data not shown). This indicates that all five NF-kB subunits are growth inhibitory in keratinocytes in vitro, consistent with results in HeLa epithelial cells (Bash et al., 1997) . We next tested whether NF-kB has effects on the proliferation of primary dermal fibroblasts. No NF-kB subunit inhibited fibroblast proliferation ( Figure 2b ). The continued overexpression of each NF-kB subunit was confirmed by Western analysis 4 days after transduction ( Figure 2c ). These data demonstrate differential growth effects in primary epidermal and dermal skin cells and are also compatible with previously reported differential effects of the NF-kB inducer TNF-a on the proliferation of these cells types (Sugarman et al., 1985; Vieira et al., 1996; Kouba et al., 2001) . To investigate the basis for the different cellular responses to NF-kB activation, we analysed the expression levels of 12 435 genes in primary human keratinocytes and fibroblasts after high-efficiency transduction with p50 and p65 retrovectors. Induction of NF-kB activity in p50/p65 transduced cells was confirmed by Northern analysis for the known NF-kB target MCP-1 ( Figure 3a ) and via reporter gene assays (Figure 3b ). Super-repressor IkBaM suppresses the induction of MCP-1 by p50/p65, further indicating that these NFkB subunits are biologically active. TNF-a addition demonstrates a dose-dependent induction of NF-kB activity and indicates that the levels of NF-kB activation in this experiment are within a biologically relevant Figure 2 Growth effects of NF-kB in keratinocytes and fibroblasts. (a) NF-kB subunit growth effects in keratinocytes. Active c-Rel, RelB and p52 as well as LacZ control were overexpressed in keratinocytes using an amphotropic retrovirus at >95% efficiency and growth kinetics determined. (b) NF-kB subunit growth effects in fibroblasts. NF-kB subunits p50 and p65 simultaneously (p50/p65), c-Rel, RelB and p52 as well as super-repressor IkBaM were expressed in fibroblasts at >95% efficiency and cell growth determined. Data represent triplicate independent transductions. (c) Continued overexpression of each subunit was confirmed in both keratinocytes and fibroblasts during this growth experiment by Western analysis performed on cell lysates 4 days after transduction. Super-repressor IkBaM overexpression is confirmed in the last panel of this figure; endogenous IkBa (endo) and truncated mutant IkBaM expression are denoted with arrows NF-jB target genes in epithelial cells K Hinata et al range (Figure 3b) . At 18 h after NF-kB transduction, 162 genes changed expression levels at least by 1.5-fold in either fibroblasts or keratinocytes in response to NFkB, as verified in at least quintuplicate independent experiments (Tables 1 and 2 ). The largest set of genes altered were those involved with inflammation and the immune response (41 genes). NF-kB altered seven genes involved in cell death, including known apoptosis inhibitors TRAF1, c-IAP1 and IEX-1. NF-kB altered 30 genes involved in adhesion or matrix remodeling, including MMP9, MMP1, t-Pa and u-Pa. In all, 15 proliferation-related genes changed expression in response to NF-kB, notably proliferation and migrationassociated FGF2, FGF5 and cyclin B1 in fibroblasts and the proliferation inhibiting cyclin-dependent kinase inhibitor (CKI) p21 CIP1 in keratinocytes. One gene induced in both keratinocytes and fibroblasts is GIF, which encodes a low molecular weight cysteine-rich metal-binding protein (Uchida et al., 1991; Erickson et al., 1994) .
Selective induction of p21 CIP1 by NF-kB in keratinocytes but not in fibroblasts was confirmed at the protein level (Figure 4a) . Differential p21 CIP1 induction may be important in determining NF-kB proliferation effects as both cell types are sensitive to p21 CIP1 blockade of proliferation (Figure 4b ) when overexpressed at similar levels (Figure 4c ) in the G1/S transition (Harper et al., 1993; Niculescu et al., 1998; Seitz et al., 2000a) . Expression of both NF-kB p50/p65 and p21 CIP1 in keratinocytes caused a decrease in cyclin-dependent kinase activity (Figure 4d) , as anticipated given their growth inhibitory effects. GIF induction by NF-kB was confirmed in both keratinocytes and fibroblasts by Northern analysis (Figure 5a ). We also observed a time-dependent increase in GIF expression levels using an inducible p65-estrogen receptor fusion activated by the addition of 4-hydroxytamoxifen (40 HT) (Zhang et al, manuscript in preparation) in a fashion similar to a c-Rel-ER fusion (Zurovec et al., 1998) (Figure 5b ). GIF is known to cause growth inhibition in neural cells in vitro (Uchida et al., 1991; Erickson et al., 1994) . To investigate GIF effects in skin cells, GIF was expressed at high efficiency in dividing primary human keratinocytes and fibroblasts by retroviral transduction. When expressed at similar levels (Figure 5f ), GIF causes growth inhibition in keratinocytes but not in fibroblasts, with no observed changes in cell death by trypan blue staining (Figure 5e and data not shown).
Discussion
In this work, we examined NF-kB effects on gene expression in epidermal keratinocytes and dermal fibroblasts. While displaying similar trends regarding genes involved in inflammation and apoptosis, NF-kB differentially regulated proliferation-associated genes. In keratinocytes, but not in fibroblasts, NF-kB induced p21
CIP1 . This finding is in agreement with the prior observation that p21 CIP1 RNA levels can be regulated as a function of keratinocyte NF-kB activity (Seitz et al., 2000a) . In fibroblasts, but not in keratinocytes, NF-kB increased the levels of genes promoting proliferation such as cyclin B1, FGF2 and FGF5. p21 CIP1 alone is sufficient to inhibit the proliferation of both keratinocytes and fibroblasts, indicating that the lack of its induction in fibroblasts may be responsible in part for the failure of NF-kB to suppress fibroblast proliferation. In contrast, GIF was induced by NF-kB in both cell types but was sufficient to inhibit the growth only of keratinocytes, suggesting involvement of additional cellular factors important in GIF effects on proliferation. It is of interest to note that p21 CIP1 and GIF promoters both contain canonical NF-kB binding sites; however, our data do not distinguish direct NF-kB targets from downstream changes. Our findings suggest two paradigms for how a transcription factor effects distinctive cellular responses within different cellular contexts. The first relies on differential target gene induction. In this setting, a particular cellular response Table 1 Genes induced by NF-kB in keratinocytes and fibroblasts NF-jB target genes in epithelial cells K Hinata et al is dependent on the target genes induced by the transcription factor, exemplified by the differential induction of p21 CIP1 . The second paradigm is cell intrinsic in which a transcription factor may regulate the same target gene in multiple settings but additional cellular factors dictate how a specific cell type will respond. This cell intrinsic influence was observed in these studies with GIF, similar to prior studies with other transcription factors such as the myogenic regulators (Schafer et al., 1990) .
Gene expression changes indicate that NF-kB is proinflammatory and antiapoptotic in both epidermal and dermal cells, but its effects differ with respect to proliferation. These functions may correspond to the physiological processes occurring in different areas of the skin in homeostasis and in response to injury. In the dermis, the role of NF-kB may be to promote inflammation and wound healing in response to trauma. In epidermis, NF-kB appears to mediate several different spatially localized roles. In the basal layer, for example, NF-kB may promote cell cycle arrest prior to outward migration (Seitz et al., 2000a) . In agreement with this model, inactivating the IKK complex member necessary for NF-kB induction, IKKg, generates epidermal hyperplasia and apoptosis (Makris et al., 2000; Schmidt-Supprian et al., 2000) . Of note, we observe no global increase in differentiation gene expression triggered by NF-kB in keratinocytes, in accord with the data that prodifferentiation effects of IKKa are NF-kB independent (Hu et al., 1999 (Hu et al., , 2001 Li et al., 1999; Takeda et al., 1999) . While recent data demonstrated that epidermal ablation of IKKb did not exert dramatic epidermis-intrinsic effects on proliferation, NF-kB activity was not completely inhibited in this setting (Pasparakis et al., 2002) . It is therefore possible that the importance of IKKb in epidermis may be to mediate the inflammatory arm of NF-kB action in epidermis. Other regulators, such as IKKa which is known to alter intrinsic epidermal cell proliferative activity (Hu et al., 2001) , may mediate NF-kB proliferative effects, possibly through differential induction of specific NF-kB subunits and crossregulatory factors. The patterns of gene expression in epidermal and dermal cells that we have observed thus indicate that NF-kB influences multiple biologic processes in different locations within skin tissue and provide paradigms of differential tissue effects by members of the same transcription factor family.
Materials and methods

Cell culture and gene transfer
Normal primary human keratinocytes and fibroblasts were isolated, grown and transduced with retroviral expression vectors as described (Choate et al., 1996; Deng et al., 1997) . Keratinocyte and fibroblast populations were confirmed Table 2 Genes reduced by NF-kB in Keratinocytes and fibroblasts NF-jB target genes in epithelial cells K Hinata et al >98% pure by morphologic analysis and immunochemistry using antibodies to keratin 5 and a5 integrin, respectively. Retroviral expression vectors encoding p21 CIP1 and NF-kB p50, p50DSP and IkBaM super-repressor were generated as described (Seitz et al., 1998) . The vector encoding RelA/p65 was constructed by isolating the 1.7 kb HindIII-NotI fragment from the p65 (RelA)/pBSK+ plasmid and cloning into the HindIII-NotI sites of the retroviral expression vector LZRS (Kinsella and Nolan, 1996) . The retroviral vector encoding p52 was constructed using the HindIII-SalI insert from the p100-XhoI/RSV plasmid into LZRS. C-rel and RelB cDNAs were cloned into LZRS using EcoRI sites. The retroviral expression vector encoding GIF was constructed by PCR amplification of GIF cDNA (GeneStorm Expression Ready Clones, Research Genetics, Huntsville, AL, USA). The sequence of 5 0 primer was 5 0 -CACCATGGACCCTGAGACCTGCC-3 0 , and the 3 0 Figure 4 p21 CIP1 is an NF-kB target in primary keratinocytes but not fibroblasts, and is sufficient to cause growth inhibition in both cell types. (a) Western analysis of whole cell extracts from keratinocytes and fibroblasts transduced with p50 and p65 (p50/p65) or LacZ control. Note the NF-kB induction of p21 CIP1 in keratinocytes but not in fibroblasts. BRG1 is included as a loading control. (b) Keratinocytes and fibroblasts were transduced with retrovirus overexpressing p21 CIP1 , and cell growth determined. Data represent triplicate independent transductions; GFP and LacZ marker retroviruses were used as control. (c) Continued overexpression of p21 CIP1 was confirmed by Western analysis 4 days after transduction. (d) IP-Kinase assay confirms the decrease in cdk activity with NF-kB in keratinocytes. Extracts of primary keratinocytes transduced with retrovectors noted at the top of the panel were immunoprecipitated with antibodies to cyclin E and kinase activity determined using histone H1 as a substrate NF-jB target genes in epithelial cells K Hinata et al primer used was 5 0 -AGTCTGGCAGCAGCTGCACTTC-3 0 . This PCR product was sequence verified and inserted into the BamHI and NotI sites of the retroviral vector LZRS. Retroviral expression vector encoding a tamoxifen (4OHT)-inducible p65 (p65-ER) was a gift of JY Zhang (manuscript in preparation), and 4OHT was added at 25 nm for p65-ER activation. For cell proliferation studies, normal human primary keratinocytes and fibroblasts were seeded 10 000 cells per 962 mm 2 well in six-well plates. All data represent triplicate independent transductions analysed at each time point.
Immunoblotting and luciferase assays
Western blotting of cell extracts separated by 8% SDS-PAGE was performed with antibodies directed against each NF-kB subunit (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Antibodies specific for BRG1, a constitutively expressed nuclear protein, were used as loading control. Transient transfection of keratinocytes and fibroblasts was performed using FuGENE-6 (Roche, Indianapolis, IN, USA) as per manufacturer's instructions to verify NF-kB activity using an NF-kB-luciferase reporter construct after transduction with p50/p65 or IkBaM. Transfection efficiency was monitored by cotransfection with a CMV-Renilla luciferase construct (Promega, Madison, WI, USA). TNF-a was added to cells transduced with retroviruses encoding either control (LacZ or GFP) or IkBaM at 1, 5 or 10 ng/ml media for 5 h before lysis and analysis according to the manufacturer's instructions (Promega, Madison, WI, USA).
Immunohistochemistry
Skins from two lines of mice transgenic for NF-kB-dependent LacZ expression (Schmidt-Ullrich et al., 1996) were preserved and frozen in OCT. Sections were cut 6 mm thick and X-gal stained as described (Schmidt-Ullrich et al., 1996) . Antibodies specific for Keratin 14 (K14) (Dako, Carpinteria, CA, USA) were used at a 1 : 100 dilution in PBS and visualized with avidin-biotin complex and DAB (Vector Laboratories, Burlingame, CA, USA) to demarcate the basal layer of the epidermis. Sections were counterstained with hematoxylin and eosin.
Kinase assay
Primary human keratinocytes were transduced with retroviruses encoding p50 and p65, IkBaM, p21 CIP1 , or LacZ or Figure 5 GIF is an NF-kB target in both keratinocytes and fibroblasts, but causes growth inhibition only in keratinocytes. (a) Keratinocytes and fibroblasts were transduced with retroviruses encoding NF-kB subunits p50/p65 or with control GFP or LacZ. RNA was harvested 18 h after transduction. Northern analysis confirms the induction of GIF by NF-kB. (b) Cells were transduced with retrovirus encoding the p65-estrogen receptor fusion (p65-ER) construct activated by addition of 4-hydroxytamoxifen (4OHT). RNA was harvested 0, 4, 9, 18 and 30 h after 4OHT addition, and Northern blotting was performed with probes specific for GIF or GAPDH as control. (c) Retrovirus overexpressing GIF was used to transduce keratinocytes and fibroblasts and cell growth determined. Data represent triplicate independent transductions; GFP and LacZ marker retroviruses were used as control. (d) Continued overexpression of GIF was confirmed by Northern analysis 4 days after transduction with retrovirus encoding GIF Lysates were incubated overnight with antibody specific for human cyclin E (Pharmingen, San Diego, CA, USA). Antibody complexes were precipitated for 5 h with A/G beads (Santa Cruz Biotechnologies, Santa Cruz, CA, USA) and washed in IP lysis buffer. The kinase reaction was performed in 20 ml reaction buffer (100 mm HEPES pH 7.5, 10 mm MgCl, 1 mg/ml BSA, 10 mm DTT, protease and phosphatase inhibitors, 1.5 mCi g-32 P ATP, 0.375 mm ATP and 1000 ng Histone H1 (Roche, Indianapolis, IN, USA)) for 30 min at 301C. The reaction was stopped with the addition of 5 Â sample buffer and boiled for 5 min prior to separation by 12% SDS-PAGE and transfer onto PVDF membrane. Blots were later probed for cyclin E expression using antibodies from Santa Cruz Biotechnologies (Santa Cruz, CA, USA).
Gene expression profiling
Total RNA was prepared using the RNeasy kit (Qiagen, Germany) from primary human keratinocytes and fibroblasts 18 h after transduction with p50 and p65 simultaneously or with GFP or LacZ as control. Northern blotting was performed on these RNA samples to verify NF-kB p50 and p65 expression and the induction of known NF-kB target gene MCP-1 as well as IkBaM inhibition of MCP-1 by superrepressor IkBaM, with GAPDH used as control. For Affymetrix GeneChips (Affymetrix, Santa Clara, CA, USA), 5 mg of mRNA was purified using oligo-dT conjugated beads (OligoTex kit, Qiagen, Germany). cRNA was prepared from mRNA by first denaturing at 701C with 0.1 nmol T7-tagged oligo-dT primer (GGCCAGTGAATTGTAATACGACT-CACTATAGGGAGGCGG-(dT) 24 ), cooled on ice, then reverse transcribed with SSII Reverse Transcriptase (Life Technologies, Rockville, MD, USA) at 371C for 1 h. Second strand cDNA was synthesized in Second Strand Reaction Buffer using 10 units DNA Ligase and 40 units DNA Polymerase I in the presence of 2 units RNaseH and 30 mm dNTPs for 2 h at 161C. Double-stranded cDNA was extracted with phenol/chloroform. A total of 1 mg of cDNA was used to prepare biotin-labeled (CTP and UTP) cRNA by in vitro transcription using the BioArray High Yield RNA Transcript Labeling Kit (Enzo, Farmingdale, NY, USA) as per the manufacturer's instructions. The labeled cRNA was purified using RNeasy spin columns (Qiagen, Germany) and fragmented in 40 mm Tris-acetate pH 8.1, 100 mm KOAc and 30 mm MgOAc at 941C for 35 min. Hybridization was performed to Affymetrix human U95A gene chips (Affymetrix, Santa Clara, CA, USA). Affymetrix chip hybridization was normalized to overall chip fluorescence levels. For Clontech Human Cancer Atlas Arrays (Clontech, Palo Alto, CA, USA), 5 mg of total RNA was used to prepare 32P-labeled cDNA probes as per the manufacturer's instructions. Clontech arrays were normalized to the panel of housekeeping genes positive controls on the arrays. Hybridization signal strength was quantitated using ImageQuant software and PhosphorImager Storm 820 (Molecular Dynamics Inc., Sunnyvale, CA, USA). Changes in the expression of an individual gene were judged significant if it changed at least 1.5-fold in triplicate with Clontech arrays and at least 1.5-fold in duplicate with Affymetrix chips.
